Tag: cancer
-
Trial to Test Ultrasound/MRI for Brain Cancer
A developer of a technology that combines ultrasound and MRI scans plans to begin a clinical trial of its techniques to improve delivery of drugs to treat a form of brain cancer.
-
Genome Editing Enhances CAR T-Cells to Fight Cancer
A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells.
-
Biotech, Cancer Center Partner on T-Cell Research
A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system.
-
Biotech Licenses Mayo Clinic Microbiome Research
A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases.
-
Trial Underway Testing Personal RNA Cancer Drug
A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells.
-
Alliance Exploring Microbiome on Cancer Immunotherapy
A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body.
-
Zymeworks, Janssen in $1.45B Antibody Licensing Deal
Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets.
-
Cancer Center, Analytics Company Partner on Precision Care
Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients.
-
Lab-On-Chip Device Simulates Tumor Microenvironment
Biomedical engineers designed a device that simulates the supportive environment in which tumors grow, and in tests was shown to work as well as lab mice for assessing cancer drugs.
-
Cancer Drug Price Rises Shown Unrelated to Competition
An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market.